Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Joint working varied success!

231 views

Published on

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Joint working varied success!

  1. 1. Joint Working - Varied Success! Amanda J Schofield Quality Improvement Lead Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate 26.06.13
  2. 2. NHS | Presentation to [XXXX Company] | [Type Date]2 Overview • A brief overview of each project • What went well • Barriers • Key points for future project
  3. 3. GMCCSN Joint Working Proposals 1.Mapping the provision of Anticoagulation Services for patients with Atrial Fibrillation (AF) across Greater Manchester (GM) – Boehringer Ingelheim (July 2010 – 2011) 2.The Management of Patients with Deep Vein Thrombosis in GM – Bayer Healthcare (February 2013 - Present) 3.Door In Door Out Project – Company A & Company B (January 2013 – Present) 3 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  4. 4. 1. GMCCSN, GMMMG & Boehringer Ingelheim Initiation • Government directive on Atrial Fibrillation and stroke prevention • New Oral Anticoagulants – Licensed • Commissioned by GM Association of PCT’s • Three way partnership • Open and Transparent 4 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  5. 5. GMCCSN, GMMMG & Boehringer Ingelheim Key Points • Detailed joint working agreement • Shared vision • Shared project management • Knowledge sharing • Pooling of resources • Outcomes were patient focused 5 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  6. 6. GMCCSN, GMMMG & Boehringer Ingelheim Project Aims • Examine care pathways for patients with AF • Understand the provision of anticoagulation services • Achieve the best outcomes for patients in terms of clinical efficacy and cost effectiveness • A controlled introduction from a financial and new clinical intervention perspective 6 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  7. 7. GMCCSN, GMMMG & Boehringer Ingelheim Deliverables • GM algorithms • Care pathway • GRASP AF implementation • Most effective prescribing for AF patients 7 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  8. 8. 2. GMCCSN & Bayer Healthcare Initiation • GMMMG and GM commissioners agreement for GMCCSN to look at the clinical pathway for Venous Thromboembolim (specifically DVT) • Extensive clinical support to evaluate the protocol and guidance • New oral anticoagulation therapy licensed for DVT • New NICE guidance released in June 2012 8 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  9. 9. GMCCSN & Bayer Healthcare Key Points • Detailed Joint working agreement drafted • Shared vision • Shared project management • Pooling of resources • Knowledge sharing • Outcome patient focused 9 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  10. 10. GMCCSN & Bayer Healthcare Project Aims • To improve and standardise the management of patients with a DVT across Greater Manchester • The development of a new protocol and pathway to manage patients with suspected DVT within Greater Manchester • The development of a structured, consistent and organised approach in the management of DVT • Improve patient outcomes 10 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  11. 11. GMCCSN & Bayer Healthcare Outcome • Not a joint working project • Unanimous decision from project steering group members • Historical suspicion • Bayer Healthcare invite • Standardised protocol development continues • Collaborative GMMMG prescribing guidance 11 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  12. 12. 3.GMCCSN & Company A and Company B Initiation • Call to Balloon Time – national guidance 150 minutes • A GM pathway flow problem had been indentified • Project mandated by GMCCSN Cardiac Board • Door – In – Door – Out (DIDO) steering group • GMCCSN approached by company A to work jointly • Advice from GMMMG to approach Company B NHS | Presentation to [XXXX Company] | [Type Date]12
  13. 13. GMCCSN & Company A and Company B Key Points • Joint working agreements drafted • Clinical engagement and agreement from the beginning • Agreement patient outcome focused • Individual companies input • Pooling of resources • NHS reconfiguration NHS | Presentation to [XXXX Company] | [Type Date]13
  14. 14. GMCCSN & Company A and Company B Project Aims • Ensure that all patients receive effective yet extremely prompt assessment and referral from their local ED to the heart attack centre for their treatment. • Target DIDO time of 30 minutes across GM. 14 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  15. 15. GMCCSN & Company A and Company B Outcome • Not a joint working project • GM treatment pathway - competition • Company B supporting training and sponsorship • Openness and transparency • NHS reconfiguration • Communication • Time 15 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  16. 16. Varied Success • Patient focused • Governance • Shared benefits • Pooled resources • Engagement • NHS Reconfiguration • Communication • A Competitive market 16 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  17. 17. What does success look like? • Have a clear understanding from beginning • All cards on the table • Detailed plans • Communication (internal/external) • Leadership • Decision makers – who are they? • Trust • Commitment 17 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
  18. 18. Key Differences NHS England GM Lancs & South Cumbria SCN & Senate 26/06/1318 Key differentiators POOLING of resources by NHS/pharmaceutical company(ies) Detailed joint working agreement Outcomes (for patients, NHS, company(ies)) clearly articulated and measured Details of arrangements made public
  19. 19. Contact information: Name: Amanda Schofield Job title: Quality Improvement Lead Company: Greater Manchester, Lancashire and South Cumbria SCN and Senate Email: a.schofield1@nhs.net Tel: 07795127368 19 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13

×